Dynamic CRA for Oncology Studies in Finland

Fortrea; Helsinki; On-site; EUR 55,000 - 75,000; Full time

Job summary

Fortrea is seeking a Clinical Research Associate located in Southern Finland to oversee sponsor-dedicated trials. The role emphasizes site management, monitoring across study phases, and strict regulatory compliance.

You will verify informed consent, perform source data verification, and ensure data integrity while collaborating with the study team. Travel to sites may be required, and oncology exposure is valued for development.

Qualifications

• Understanding of ICH GCP Guidelines and local regulatory requirements.
• Thorough knowledge of monitoring procedures.
• Understanding of the clinical trial process.
• Fluent in local office language and in English, both written and verbal.
• Relevant experience may substitute for educational requirements.

Responsibilities

• Site management and monitoring in accordance with Fortrea SOPs, ICH GCP, and sponsor requirements.
• Conduct pre-study, initiation, routine monitoring, close-out visits and data verification.
• Prepare and implement project monitoring plans and site initiation materials.
• Ensure informed consent and protocol adherence and regulatory compliance.
• Maintain data integrity through source data verification and query resolution.
• Track regulatory documents, trial materials, and IP inventory.
• Attend meetings, train staff, and support training of new employees.
• Ensure audit readiness and quality control at the site.

Skills

GCP knowledge

Monitoring procedures

Clinical trial process

Fluent English

Finnish language

Education

Bachelor's degree or equivalent

Job description

Fortrea is seeking a Clinical Research Associate located in Southern Finland to oversee sponsor-dedicated trials. The role emphasizes site management, monitoring across study phases, and strict regulatory compliance.

You will verify informed consent, perform source data verification, and ensure data integrity while collaborating with the study team. Travel to sites may be required, and oncology exposure is valued for development.